 |
市場調査レポート
商品コード
1441245
涙器の世界市場規模、シェア、成長分析、製品別、用途別-産業予測、2023～2030年Global Lacrimal Devices Market Size, Share, Growth Analysis, By Product(Intubation Sets, Stents And Tubes), By Application(Glaucoma, Dry Eye) - Industry Forecast 2023-2030 |
||||||
| 涙器の世界市場規模、シェア、成長分析、製品別、用途別-産業予測、2023～2030年 |
|
出版日: 2024年02月17日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の涙器市場規模は2022年に2,001億6,000万米ドルと評価され、予測期間（2024～2031年）のCAGRは8.5%で、2023年の2,171億7,000万米ドルから2031年には4,171億1,000万米ドルに成長する展望です。
涙器市場は、さまざまな年齢層で眼科疾患に対する認識と診断が高まっているため、大幅な成長を遂げています。
目に関連する疾患の増加に伴い、穿刺プラグ、涙器ステント、灌流システムなどの高度な涙器に対する需要が高まっています。さらに、技術や手術方法の進歩により患者の治療成績が向上し、市場の拡大に寄与しています。人口の高齢化とそれに伴う加齢に関連した目の問題の増加も、市場の持続的成長に寄与しています。医療プロバイダーやメーカーは、ケアの質と患者の快適性の向上に重点を置き、進化する涙液障害患者のニーズに応える革新的なソリューションの開発に積極的に取り組んでいます。規制要因や償還政策も、市場の力学を形成する上で重要な役割を果たしています。全体として、涙器市場は、患者中心のソリューションと治療結果の向上にますます重点を置くようになり、眼科機器セグメントの企業にとって有望な機会を提示しています。
目次
エグゼクティブサマリー
- 市場概要
- 繁栄と衰退
調査手法
- 情報調達
- セカンダリとプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資の分析
- 主要成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
涙器の世界市場：製品別
- 市場概要
- 挿管セット
- ステントとチューブ
- 拡大器
涙器の世界市場：用途別
- 市場概要
- 緑内障
- ドライアイ
- 涙腺の炎症
涙器の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- FCI Ophthalmic（フランス）
- Kaneka Corporation（日本）
- Lacrimedics, Inc.（米国）
- Cook Group（米国）
- BVI（英国）
- Rumex International（米国）
- Bess Medical Technology GmbH（ドイツ）
- Alcon（スイス）
- Bausch and Lomb Incorporated（米国）
- BraunMelsungen AG（ドイツ）
- OASIS Medical, Inc.（米国）
- Beaver-Visitec International（米国）
- FC Optics Ltd.（イスラエル）
- D.O.R.C. Dutch Ophthalmic Research Center（オランダ）
- OptiMedica Corporation（米国）
- MicroSurgical Technology（米国）
- Diamatrix Ltd.（英国）
- FCI S.A.S.（フランス）
- Novartis AG（スイス）
- Eye Kon Medical, Inc.（米国）
Global Lacrimal Devices Market size was valued at USD 200.16 Billion in 2022 and is poised to grow from USD 217.17 Billion in 2023 to USD Billion 417.11 by 2031, at a CAGR of 8.5% during the forecast period (2024-2031).
The lacrimal devices market is experiencing substantial growth due to the rising awareness and diagnosis of ophthalmic conditions across various age demographics.
With an increase in eye-related disorders, there is a growing demand for advanced lacrimal devices such as punctual plugs, lacrimal stents, and irrigation systems. Furthermore, advancements in technology and surgical methods have resulted in better patient outcomes, contributing to the expansion of the market. The aging population and the corresponding rise in age-related eye issues also contribute to the market's sustained growth. Healthcare providers and manufacturers are actively working on developing innovative solutions to meet the evolving needs of patients with lacrimal disorders, with a focus on improving care quality and patient comfort. Regulatory factors and reimbursement policies also play a significant role in shaping the market's dynamics. Overall, the lacrimal devices market presents promising opportunities for companies in the ophthalmic devices sector, with an increasing emphasis on patient-centred solutions and enhanced treatment results.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lacrimal Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.
Global Lacrimal Devices Market Segmental Analysis
The global lacrimal devices market is segmented on the basis of product, application and region. Based on product the market is segmented as intubation sets, stents and tubes, dilators. On the basis of application, the market is segmented as glaucoma, dry eye, and lacrimal gland inflammation. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Lacrimal Devices Market
The main factor fuelling the lacrimal devices market is the rising prevalence of eye disorders worldwide. Elements such as aging populations, shifting lifestyles, and increased screen usage lead to conditions such as dry eye syndrome and other lacrimal system disorders. This results in an increased need for lacrimal devices for diagnosing and treating these conditions, driving the growth of the market.
Restraints in the Global Lacrimal Devices Market
A significant challenge in the lacrimal devices sector is the strict regulatory environment and potential delays in obtaining approvals for new products or modifications. Regulatory bodies, especially in North America and Europe, have rigorous standards for medical devices, which can result in prolonged timelines for market introduction. These regulatory obstacles can hinder innovation and market expansion, affecting both established companies and new entrants in the field.
Market Trends of the Global Lacrimal Devices Market
A notable trend in the lacrimal devices market is the growing inclination towards minimally invasive procedures. Patients and healthcare providers are favouring less invasive methods for treating lacrimal system disorders due to their advantages, including faster recovery times, fewer postoperative complications, and enhanced patient comfort. This shift is spurring innovation in the creation of minimally invasive lacrimal devices, such as micro endoscopes and specialized catheters, to meet the changing preferences in patient care.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Lacrimal Devices Market by Product
- Market Overview
- Intubation Sets
- Stents And Tubes
- Dilators
Global Lacrimal Devices Market by Application
- Market Overview
- Glaucoma
- Dry Eye
- Lacrimal Gland Inflammation
Global Lacrimal Devices Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- FCI Ophthalmic (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kaneka Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lacrimedics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Group (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BVI (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rumex International (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bess Medical Technology GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alcon (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bausch and Lomb Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BraunMelsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OASIS Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beaver-Visitec International (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- FC Optics Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- D.O.R.C. Dutch Ophthalmic Research Center (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OptiMedica Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroSurgical Technology (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Diamatrix Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- FCI S.A.S. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eye Kon Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
